Glutathione

Think of glutathione as a buffer, the way a pool’s chemistry resists swings in acidity. Each time it neutralizes an oxidant, a reduced glutathione molecule pairs with another and becomes oxidized glutathione. The cell then recycles it back. The ratio of the two forms works as a gauge of how stressed a cell is.

That gauge is measurable in blood. In the 2015 oral glutathione trial, the ratio of oxidized to reduced glutathione in whole blood fell in both dose groups after six months, a sign of lower oxidative stress. That is a measured change in a controlled trial, the standard worth holding every glutathione claim to.

Glutathione also tunes the immune system. It helps regulate cytokine production and immune responses, and in the same trial, natural killer cells, the immune cells that destroy infected and abnormal cells, became more than twice as active on the higher dose compared with placebo at three months.

There is a quieter role too. Glutathione attaches to proteins in a process called glutathionylation, which changes how those proteins behave and helps relay signals inside the cell. That is why researchers describe it as a regulator of cell behavior and not only a cleanup crew.¹²

Outside cells, an enzyme called gamma-glutamyl transferase, GGT, breaks glutathione down and makes its amino acids available to cells, which then rebuild glutathione inside. Glutathione outside a cell can be dismantled and rebuilt within it, which is one reason the cell’s own production line matters so much.

GGT is also a familiar line on a blood test. Doctors have long used it as a marker of liver strain and alcohol intake. Conditions that raise it, such as blocked bile flow, heavy drinking and some medicines, increase free radical production and the threat of glutathione depletion.

High GGT carries weight of its own. In population studies, people with high serum GGT have higher mortality and more coronary heart disease, type 2 diabetes and stroke. Part of that comes from other risk factors that travel with it, and part of it is independent. A test most people never look at turns out to say something about their oxidative load.

Because cysteine sets the pace, the body can make glutathione from several upstream sources. Cystine, methionine and N-acetylcysteine, better known as NAC, all feed cysteine into tissue glutathione production. That gives you more than one way to support the same system.⁵¹

In 2011, researchers at Baylor College of Medicine asked a simple question. Do older adults have less glutathione because they burn through it, or because they make less? They traced glutathione production in 8 older and 8 younger adults using a labeled form of glycine.

The answer was production. Older adults had about half the red cell glutathione of younger people, and they made it at roughly a third of the younger rate. Their red cells held less than half as much glycine and less cysteine, and their blood showed more oxidative stress and more oxidant damage to fats.

Then came the useful part. After two weeks of cysteine and glycine, the older adults’ glutathione rose by 94.6% and their production rate more than tripled. Oxidative stress fell, and on these measures they were no longer different from the young group. The factory was intact. It had been short on parts.

The same team followed up with a randomized trial. Twenty-four older adults took glycine plus NAC, a combination called GlyNAC, or a placebo for 16 weeks. The GlyNAC group improved glutathione, oxidative stress, mitochondrial function, inflammation, insulin resistance, gait speed and strength. The trial was small and came from one group, so it needs replication. It still reframes the question from how much glutathione you can add to whether your cells have what they need to make it.³⁴

For years, the standard answer was no. Glutathione is a peptide, and the gut breaks down peptides, so dermatology reviewers still describe oral glutathione as questionable because of limited absorption. A team at Penn State tested the assumption directly with a six-month randomized, double-blind trial in 54 non-smoking adults.

Blood glutathione rose at one, three and six months on both doses. On the higher dose, levels rose 30 to 35% in red cells, plasma and lymphocytes and about 260% in cells from the inside of the cheek. On the lower dose, blood and red cell levels rose 17% and 29%. The changes grew with dose and with time.

Then the supplement stopped, and within a month levels were back to baseline. That detail is easy to skip and worth keeping. In this trial, oral glutathione behaved like a maintenance input. It raised stores while people took it, and the gain did not outlast a month off.

What the trial did not test is whether higher stores improve health in people who were not deficient. It measured glutathione levels, an oxidative stress ratio and immune markers. That is real evidence that swallowing glutathione can raise body stores, whether it arrives intact or is rebuilt from its parts, and it stops short of evidence of benefit.⁷²

IV glutathione goes straight into the blood, and injections into muscle or under the skin skip the gut, though they still have to be absorbed from the site. The harder question is what happens next. One small placebo-controlled test of IV glutathione comes from Parkinson’s disease, one of the conditions linked to glutathione deficiency.

In a 2009 double-blind pilot, 21 people whose Parkinson’s symptoms were not well controlled received IV glutathione or placebo over four weeks. Glutathione was well tolerated, with no withdrawals for side effects. Symptom scores improved slightly more on glutathione during treatment and worsened slightly more after it stopped, but neither difference was statistically significant.

Reviews of IV use across indications tell a similar story. A 2016 review found two systematic reviews of IV glutathione to prevent chemotherapy toxicity and one in Parkinson’s disease, covering 10 trials. Most reported no or minimal side effects, but every trial lasted a few doses or 4 to 12 weeks, and none studied long-term IV use.

So injections answer the delivery question without answering the outcome question. Getting glutathione into the blood is not the same as showing a benefit, and these studies do not validate a routine injection course. For a person, that argues for a clinician’s judgment and a named goal rather than a standing weekly habit.⁶⁹

Many people first hear about glutathione because of skin. It is widely used across Asia as a skin-lightening supplement, and the idea has a biological basis. Glutathione has anti-melanin and antioxidant properties, and it can shift pigment production away from dark brown melanin.

A 2019 systematic review found four clinical studies. Oral and topical glutathione brightened skin in sun-exposed areas, measured by a melanin index, with no significant difference in sun-protected skin, and showed trends toward fewer wrinkles and UV spots. Side effects were non-serious. The authors still called the evidence inconclusive because of study quality.

A 2025 review in the International Journal of Dermatology found five randomized trials of oral glutathione that reduced the melanin index compared with placebo, and topical forms that worked better at higher strengths. It also found that the effects were unsustainable once use stopped, and only one placebo-controlled IV study, which did not reach significance.

On IV use for skin, both reviews were blunt. The 2016 review warned there were no studies of IV glutathione for lightening and raised a theoretical concern that moving people from brown to red melanin could raise sun-related skin cancer risk. The 2025 review concluded that IV glutathione should not be used for lightening, given the lack of efficacy and its side effects.⁷⁸⁹

NAC, N-acetylcysteine, is a precursor of cysteine, the amino acid that limits how fast cells can make glutathione. Taking NAC is a bet on the production line. Taking glutathione is a bet on delivering the finished product, which outside cells can be broken down to its amino acids and rebuilt inside.

Each route has human data of a different kind. Oral glutathione raised blood and cell levels over six months in healthy adults. Cysteine and glycine restored glutathione in older adults within two weeks, and glycine plus NAC improved a wider set of aging measures over 16 weeks in a small randomized trial.

None of the studies cited here compares them head to head in a large trial, so there is no proven winner. Protein intake shapes how much glutathione you can make, and the small precursor studies were done in older adults, but none of that is a rule for an individual. A clinician can weigh whether direct glutathione, its building blocks or neither makes sense for you.¹⁵²³⁴

In the trials that exist, glutathione has been well tolerated. The IV Parkinson’s pilot found no safety concerns and no withdrawals for side effects, and a 2019 skin review reported only non-serious effects. A 2025 review was less relaxed about oral use, describing minimal side effects with topical glutathione and more substantial ones by mouth.

The gaps are about time and route. The 2016 review, which searched the literature through 2015, found no study of long-term IV use for any purpose, and it noted that clinics advertise IV glutathione widely, including product bought online. Every injection carries the basic risks of a needle and depends on sterile preparation.

There are specific situations to raise with a clinician first. People having cancer treatment or surgery should tell their care team about any antioxidant, and anyone pregnant or breastfeeding should ask before starting. IV glutathione for skin lightening is the use the evidence argues against most clearly.²⁶⁷⁹⁸

Most people never have glutathione measured directly, and no routine blood test stands in for it. What standard labs offer is general context a clinician can review. GGT is the obvious one to know about. It is the enzyme that breaks glutathione down outside cells, and a raised level can go with liver or bile-duct problems, alcohol or some medicines, though it does not measure glutathione itself.

Homocysteine sits upstream. It feeds the sulfur pathway that supplies cysteine, the building block that limits glutathione production, though its blood level also depends on B vitamins and kidney function and is not a measure of cysteine supply. ALT, a liver enzyme, shows whether liver cells are under stress, and hs-CRP shows whether body-wide inflammation is in the background.

Vitals Vault offers glutathione injections prescribed online by licensed US clinicians, who review your health history before deciding whether they fit. A baseline panel gives that review context on your liver, kidneys and inflammation. A later change in those markers can be worth discussing, but it cannot by itself show that glutathione did the work.⁵¹

Glutathione lives in two regulatory worlds. By mouth, it is sold in the US as a dietary supplement. As an injection, it is not an FDA-approved drug, and pharmacies compound it with a prescription. FDA’s updated 503A list from May 2026 places it in category 1, under evaluation, where FDA does not intend to act against compounders who meet the interim policy’s conditions.

Athletes have one more rule to know. Glutathione is not banned by name, but WADA restricts IV infusions and injections above a set volume within 12 hours, outside of hospital care.¹⁰¹¹¹³

Glutathione is the antioxidant your cells make for themselves, and the strongest human evidence is about supply. Oral glutathione raises stores while you take it, injections deliver it directly, and in older adults the building blocks alone restored low levels. Evidence that extra glutathione improves health in people who are not low is still thin.

If you are considering it, the question worth asking first is whether your body is short on glutathione at all. And if it is, is it short on parts, or spending glutathione faster than it can make it?²³⁴